SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
RPTX
--
0.00%
--
Repare Therapeutics initiates early-stage study of RP-3500 in solid tumors
Seeking Alpha · 4d ago
Repare Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of RP-3500
Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced the first patient has been
Business Wire · 5d ago
The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)
Benzinga · 07/16 12:31
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)
Benzinga · 07/15 11:30
Morgan Stanley Says Buy Repare Therapeutics, Sees Nearly 60% Upside
Repare Therapeutics Inc. (NASDAQ: RPTX), which is working to develop precision oncology therapies by leveraging synthetic lethal interactions in cancer, went public in June.
Benzinga · 07/14 23:03
Morgan Stanley Initiates Coverage On Repare Therapeutics with Overweight Rating, Announces Price Target of $37
Morgan Stanley analyst Jeffrey Hung initiates coverage on Repare Therapeutics (NASDAQ:RPTX) with a Overweight rating and announces Price Target of $37.
Benzinga · 07/14 13:06
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13)
Benzinga · 07/14 12:04
A Peek Into The Markets: US Stock Futures Up; Bank Earnings In Focus
Pre-open movers
Benzinga · 07/14 10:01
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector.
Benzinga · 07/12 15:25
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 07/10 11:25
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)
Benzinga · 07/08 11:31
Leaf Group, Forma Therapeutics See Activist Action
Barrons.com · 07/03 00:30
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)
Benzinga · 07/02 12:21
Repare Therapeutics 13D Filing From Orbimed Advisors Shows 8.9% Stake
Benzinga · 06/26 10:14
Repare Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced the closing of its previously announced upsized initia
Business Wire · 06/23 20:05
Shares Of Repare Therapeutics Open For Trade At $32.05; IPO Priced At $20/Share
Benzinga · 06/19 15:55
Repare Therapeutics Shares Indicated $35.50 On 293K Shares
Benzinga · 06/19 15:10
Repare Therapeutics Indicated At $41.31 On 157K Shares
Benzinga · 06/19 14:58
Shares Of Repare Therapeutics To Open For Quote At 10:35 a.m. EDT, Expected To Open For Trade After 10:45 a.m. EDT; IPO Priced At $20 Per Share
Benzinga · 06/19 14:04
Repare Therapeutics Prices 11M Share IPO @$20/Share
Repare Therapeutics Inc. (NASDAQ: RPTX) announced the pricing of its upsized initial public offering of 11,000,000 of its common shares at a public offering price of $20.00 per share. The gross proceeds to Repare, before deducting underwriting commissions and
Benzinga · 06/19 09:35